Another recent study by Baird et al. incorporated a STING ligand into a hydrogel (Matrigel) and injected it intratumourally in HNSCC tumours resected from mice to demonstrate anti-tumour activity in comparison to controls [44]. This evidence concerns the gene STING1 and neoplasm.